UBS analyst Timothy Arcuri raised the firm’s price target on Marvell (MRVL) to $105 from $95 and keeps a Buy rating on the shares. The firm updated its model following a series of supply chain checks and management comments.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVL:
- Moderately bullish activity in Marvell with shares down 5.28%
- Marvell price target raised to $115 from $95 at Oppenheimer
- Mixed options sentiment in Marvell with shares down 1.02%
- Unity, Lam, Oneok, Marvell, Credo: Trending by Analysts
- Marvell Stock (MRVL) Falls on TD Cowen’s Downgrade, Price Target Cut